Status: Not yet recruiting
Subconjunctival Humira for Boston Keratoprosthesis
This trial is studying the safety and tolerability of receiving an injection of adalimumab (Humira) during the Boston Keratoprosthesis (KPro) surgery.
Participants needed: 8
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Massachusetts Eye and Ear InfirmaryUpdated: Mar 27, 2026Locations: 1
Eligibility criteria
Age 18 years or older [+6]
Active tuberculosis or untreated latent tuberculosis (e.g., positive interferon-... [+18]